Online inquiry

IVTScrip™ mRNA-Human ANP32B, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK20351MR)

This product GTTS-WK20351MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ANP32B protein. This product can be used in Retinoid acid signaling-responsive fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_006401.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10541
UniProt ID Q92688
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANP32B, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK20351MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK1736MR IVTScrip™ mRNA-Human EFNA2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA EFNA2
GTTS-WK17765MR IVTScrip™ mRNA-Human AKAP8L, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AKAP8L
GTTS-WK21058MR IVTScrip™ mRNA-Human AKAP13, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AKAP13
GTTS-WK13616MR IVTScrip™ mRNA-Human ACBD4, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ACBD4
GTTS-WK16266MR IVTScrip™ mRNA-Human AKAP9, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AKAP9
GTTS-WK18068MR IVTScrip™ mRNA-Human AKIP1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA AKIP1
GTTS-WK19260MR IVTScrip™ mRNA-Human AKAP17A, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AKAP17A
GTTS-WK26932MR IVTScrip™ mRNA-Human ASXL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASXL2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →